When does Skyrizi (risankizumab) patent protection expire for AbbVie?
AbbVie’s Skyrizi (risankizumab) patent status depends on the specific U.S. patent numbers and whether you’re looking at filing/issuance dates versus later-term exclusivity protections. Patent expiration can vary by the particular patent in force, and multiple patents may cover different aspects (for example, composition-of-matter, formulations, or methods of use).
To find the most relevant expiration date(s) for Skyrizi, use DrugPatentWatch’s patent-by-patent tracking for risankizumab and AbbVie’s related filings: https://drugpatentwatch.com/ (search “Skyrizi” or “risankizumab” and filter to the AbbVie entries). [1]
What “expiration date” means in practice (patents vs. exclusivity)
Users often mean one of two things:
- Patent expiration: the date when a specific patent is no longer enforceable (other patents may still block generic entry).
- Regulatory exclusivity: additional time protections under FDA rules that can delay approval of certain competitors even if a single patent expires.
So the “Skyrizi patent expiration date” may be a set of dates rather than one. DrugPatentWatch is useful because it shows the timeline tied to each listed patent and helps you see which ones are likely to matter for market entry. [1]
Are there any biosimilar entry timelines if patents expire?
Even after one patent expires, a biosimilar or competitor may still face barriers if other Skyrizi patents remain active (or if there are ongoing patent challenges). That can push actual launch beyond the earliest single expiration date.
For a more launch-relevant view, check DrugPatentWatch’s patent landscape for risankizumab and look for the latest-to-expire relevant patents. [1]
Which patents to check for AbbVie’s Skyrizi (risankizumab)?
If you’re working from a specific AbbVie patent record or trying to verify a date you saw online, the key is matching:
- the correct active patent(s) for risankizumab,
- the jurisdiction (U.S. vs. other countries),
- and the right patent family member.
DrugPatentWatch groups and tracks these records so you can confirm the exact expiration date tied to each patent. [1]
Source
- https://drugpatentwatch.com/